(Q61447377)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

title

Stratification and prediction of remission in first-episode psychosis patients: the OPTiMiSE cohort study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Stéphane Jamain

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Philip McGuire

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Birte Yding Glenthøj

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Richard J. Drake

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Nicolas Glaichenhaus

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

15

Celso Arango

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

11

Iris Sommer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Olfa Khalfallah

7

0 references

Emanuela Martinuzzi

object named as

Emanuela Martinuzzi

1

0 references

Shôn Lewis

object named as

Shon Lewis

23

0 references

author name string

Susana Barbosa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Wafa Bel Haj Ali

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Cyprien Gilet

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Lionel Fillatre

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Réjane Troudet

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Guillaume Fond

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Stefan Leucht

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Paola Dazzan

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Covadonga M Diaz-Caneja

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Wolfgang Fleischhacker

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Inge Winter

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

René Sylvain Kahn

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Robert Yolken

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Laetitia Davidovic

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Dan Rujescu

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

Marion Leboyer

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

OPTiMiSE Study Group

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

language of work or name

English

0 references

publication date

17 January 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

published in

Translational Psychiatry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

page(s)

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

19 April 2020

copyright license

start time

17 January 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/s41398-018-0366-5

0 references

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Early detection and intervention in schizophrenia: a new therapeutic model

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Medications for first-episode psychosis: making a good start.

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

The promise of biological markers for treatment response in first-episode psychosis: a systematic review

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Measurement-based psychiatry: definitions of response, remission, stability, and relapse in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Remission in schizophrenia: proposed criteria and rationale for consensus

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Prediction of symptom remission in schizophrenia during inpatient treatment

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Predictors of functional and clinical outcome in early-onset first-episode psychosis: the child and adolescent first episode of psychosis (CAFEPS) study

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Association of schizophrenia and autoimmune diseases: linkage of Danish national registers

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Are some cases of psychosis caused by microbial agents? A review of the evidence

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Antibodies to infectious agents in individuals with recent onset schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Results from a hypothesis generating case-control study: herpes family viruses and schizophrenia among military personnel

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Long-term (3-year) effectiveness of haloperidol, risperidone and olanzapine: results of a randomized, flexible-dose, open-label comparison in first-episode nonaffective psychosis

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Risperidone normalizes increased inflammatory parameters and restores anti-inflammatory pathways in a model of neuroinflammation.

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Activation of Th17 cells in drug naïve, first episode schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychotics

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

A depression rating scale for schizophrenics

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Maternal infections and subsequent psychosis among offspring.

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Regularization and variable selection via the elastic net

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Combining clinical variables to optimize prediction of antidepressant treatment outcomes

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

An introduction to ROC analysis

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Building Predictive Models inRUsing thecaretPackage

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Regularization Paths for Generalized Linear Models via Coordinate Descent

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

pROC: an open-source package for R and S+ to analyze and compare ROC curves

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

eNetXplorer: an R package for the quantitative exploration of elastic net families for generalized linear models

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Proteomic approaches to identify blood-based biomarkers for depression and bipolar disorders.

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Machine learning, statistical learning and the future of biological research in psychiatry

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Beyond Lumping and Splitting: A Review of Computational Approaches for Stratifying Psychiatric Disorders

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Machine Learning for Precision Psychiatry: Opportunities and Challenges

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Stratified medicine for mental disorders

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

A genome-wide association study of autism using the Simons Simplex Collection: Does reducing phenotypic heterogeneity in autism increase genetic homogeneity?

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Medicine. Brain disorders? Precisely.

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

The importance of external validity

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Heterogeneity in schizophrenia: a cluster-analytic approach

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

The subtyping of schizophrenia in men and women: a latent class analysis

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Identifying subtypes of schizophrenia by cluster analyses

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

The structure of psychosis: latent class analysis of probands from the Roscommon Family Study

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Dimensions and classes of psychosis in a population cohort: a four-class, four-dimension model of schizophrenia and affective psychoses.

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Social cognitive impairments and negative symptoms in schizophrenia: are there subtypes with distinct functional correlates?

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Research domain criteria (RDoC): toward a new classification framework for research on mental disorders

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Anti-inflammatory drugs in psychiatry

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis.

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Nonsteroidal anti-inflammatory drugs and 5-HT₃ serotonin receptor antagonists as innovative antipsychotic augmentation treatments for schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Anti-inflammatory treatment in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

1 reference

7 January 2021

Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6.

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Cortisol and Inflammatory Biomarkers Predict Poor Treatment Response in First Episode Psychosis

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Macrophage- and dendritic-cell-derived interleukin-15 receptor alpha supports homeostasis of distinct CD8+ T cell subsets

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Interleukin 15 expression in the CNS: blockade of its activity prevents glial activation after an inflammatory injury.

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Interleukin-15 regulates proliferation and self-renewal of adult neural stem cells

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Interleukin-15 affects serotonin system and exerts antidepressive effects through IL15Rα receptor

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Brain interleukin-15 in neuroinflammation and behavior

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

CXCL12 chemokine and GABA neurotransmitter systems crosstalk and their putative roles

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Cytomegalovirus and schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

https://api.crossref.org/works/10.1038%2FS41398-018-0366-5

7 January 2021

Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning

1 reference

12 December 2020

The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.

1 reference

12 December 2020

Environmental risk factors for psychosis.

1 reference

12 December 2020

Increased interleukin-6 and tumor necrosis factor alpha in first episode schizophrenia patients versus healthy controls

1 reference

12 December 2020

eNetXplorer: an R package for the quantitative exploration of elastic net families for generalized linear models

1 reference

12 December 2020

10.1038/S41398-018-0366-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

19 April 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30655509%20AND%20SRC:MED&resulttype=core&format=json

19 April 2020

1 reference